Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • CSF-1R
    (1)
  • Interleukin
    (1)
  • Potassium Channel
    (1)
  • RAAS
    (1)
  • SARS-CoV
    (1)
  • Virus Protease
    (1)
  • Others
    (3)
Filter
Search Result
Results for "

respiratory failure

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    7
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    1
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    2
    TargetMol | Inhibitory_Antibodies
  • Recombinant Protein
    1
    TargetMol | Recombinant_Protein
Tocilizumab
T9911375823-41-9
Tocilizumab (Anti-Human IL6R) is a neutralizing antibody against human interleukin-6 receptor (IL-6R) that blocks the binding of IL-6 to IL-6R, thereby inhibiting both classical and trans signaling. It can be used to study rheumatoid arthritis and has been suggested as a possible drug for the treatment of severe COVID-19.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
Mavrilimumab
CAM 3001
T766901085337-57-0
Mavrilimumab (CAM 3001) is a monoclonal antibody with antiviral activity that targets the α subunit of the granulocytic-macrophage colony-stimulating factor (GM-CSF) receptor, inhibiting downstream intracellular GM-CSF signaling. GM-CSF may contribute to an overactive inflammatory response linked to respiratory failure and death and could be used to study rheumatoid arthritis.
  • Inquiry Price
Size
QTY